On the occassion of the European Testing Week 2020, ECDC publishes the first report monitoring progress towards the elimination of hepatitis B and C in the EU/EEA.
Tackling the undiagnosed fraction: the ECDC Guidance outlines whom, where, how and when to test for viral hepatitis and HIV and offers options for testing strategies that are applicable to all healthcare settings and beyond, e.g. self-sampling and self-testing.
Subgroups of migrant populations are often disproportionately affected by diseases such as tuberculosis, HIV, and hepatitis B and C. Consequently, screening and vaccination programmes may be of benefit for newly arrived migrants
Monitoring the responses to hepatitis B and C epidemics in the EU/EEA Member States, 2019
Technical report-
Publication
Toolkit to support the generation of robust estimates of hepatitis C prevalence
Toolkit, Technical report-
Peer-Reviewed Publication
Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting
Dec 2019
Peer-Reviewed Publication
Reorienting health systems to care for people with HIV beyond viral suppression
